More than ever, an active pharmaceutical ingredient’s (API) bioavailability is a key factor to its success. Through improvement of the final formulation you can increase the bioavailability of your API. We support you with solutions that improve poor aqueous solubility, control optimized release profiles and achieve targeted drug delivery to help boost your productivity and return on investment.
With a secure supply chain, a comprehensive formulation portfolio of over 400 Emprove® products, and outstanding global expertise, we can help solve even the trickiest bioavailability challenge. No matter the application or dosage form, our products improve the performance of APIs, so your molecules won’t get stuck in the development pipeline.
Find the right functional excipient to solve your bioavailability challenges:
|Optimized Release||Solubility Enhancement||Targeting and Drug Delivery|
|Parteck® SRP 80 (Polyvinyl Alcohol)||Parteck® MXP||Activated/ Functionalized PEGs (Polyethylene Glycols)|
|Parteck® M (Mannitol)||Parteck® SLC (Silica)||Lipids/ Synthetic Lipids|
|Parteck® ODT (Orally Disintegrating Tablet)||Meglumine||PEG Lipids|
|Parteck® Delta M (Mannitol)||Activated/ Functionalized PEGs||PLGA/PLA|
|PVA (Polyvinyl Alcohol)||PEGs (Polyethylene Glycols)||Sustained release for biological APIs|
|PEGs (Polyethylene Glycols)||Tween®|
|Activated/ Functionalized PEGs (Polyethylene Glycols)|